3 models fit Sun Life Financial Inc. Common Stock and they disagree: 1 of 3 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver68
Valued as an insurer: Residual income, P/E comparison, and Dividend discount.
ACCE opinionSun Life Financial Inc. Common Stock (SLF)
Fair value (3 models)
$54.68
ACCE price target
$84.00
Rating
Overvalued
Horizon
12 months
Fair value published on 19 Oct 2026, 19:04 CEST; previously $54.04 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 20 Sept 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $79.08 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison, Dividend discount, and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
44.6% above
-30.9% to fair value
ACCE score
73
out of 100
Analysts
43% buy
14 covering
P/E
18.5x
forward 12.9x
1-year return
+28.9%
Dividend yield
3.35%
Sun Life Financial Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Sun Life is a Canadian diversified insurer whose earnings come from individual and group life and health insurance, group benefits, and wealth and asset management, including the MFS investment franchise it owns in the United States. Its moat is a long-standing distribution footprint across Canada and Asia, combined with a fee-generating asset management arm that cushions the cyclicality of underwriting. Revenue growth of 7.5% and a 13.1% return on equity suggest the core businesses are compounding without leaning heavily on leverage, and the earnings base is broad enough that no single product line drives the story. The stock trades at 18.1 times trailing earnings but 12.8 times forward, a gap that implies the market expects a meaningful step-up in profit, so the first question for the portfolio manager is whether consensus estimates for that rebound hold up under scrutiny. The company sits outside major indices, which may explain part of the valuation discount, and warrants a deeper look at its Asian insurance exposure and interest-rate sensitivity before any position is sized.
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
moderate
5-year revenue stagnation
5y revenue CAGR of -0.5% suggests structural headwinds despite recent 7.5% YoY growth, which may reflect a cyclical bounce rather than sustained expansion.
moderate
Earnings growth sustainability unclear
43.2% YoY earnings growth is sharp relative to flat long-term revenue trend. Margin expansion or one-time items may not repeat; forward P/E of 13.1 vs current 18.0 implies market expects normalization.
AI research notes
AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Sun Life generates strong free cash flow of CAD 13.6B with a 22.3% yield, supporting the 4.8% dividend.
Recent earnings beat expectations by 5.0% and revenue grew 7.5% year over year, signaling operational momentum.
The company trades at 13.1x forward earnings while shrinking share count by 1.4%, boosting per-share value.
Why it could disappoint
Consensus fair value sits 29.8% below the current share price of $76.99, suggesting significant overvaluation.
Five-year revenue growth averages negative 0.5% annually, indicating the business lacks durable expansion.
Return on invested capital of 7.0% trails the cost of capital, destroying shareholder value over time.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where SLF's valuation models land
Price
$79.08
Model fair value
$54.68
Model range
$43.21 to $67.32
Fair value $54.68
Price $79.08
The price is above the whole model range.
Model
Fair value
Upside
Dividend discount
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores